Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism

Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Other)
Overall Status
Recruiting
CT.gov ID
NCT05826080
Collaborator
(none)
59
1
36
1.6

Study Details

Study Description

Brief Summary

The purpose of our research is to evaluate the value of ACTH stimulation in AVS especially in lateralization is still controversial.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Primary aldosteronism (PA) is thought to be the most common secondary endocrine form of hypertension. A recent published study revealed that the prevalence of PA in patients with newly diagnosed hypertension in China was at least 4%. Compared with patients with essential hypertension with similar blood pressure, patients with PA have significantly higher atrial fibrillation, myocardial infarction, heart failure, stroke, deterioration of renal function and all-cause mortality. Therefore, early and systematic implementation of effective surgical or medical treatment is essential to prevent or reverse the excess vascular events and mortality of these patients.

    Adrenal venous sampling (AVS) is key for reliable subtype identification recommended by different guidelines and consensus statements. However, AVS is a complex, technically challenging and expensive procedure, requiring proficient and dedicated interventional radiologists. More importantly, the standardised procedure and method of AVS have not been unified10. Adrenocorticotropic hormone (ACTH) infusion is employed by many centers to maximize the gradient in cortisol from the adrenal vein to the inferior vena cava, and to maximize aldosterone secretion from an aldosterone-producing adenomas (APA) and thus avoid the risk of sampling during a relatively quiescent phase of aldosterone secretion. There is no debate that ACTH stimulation increases the selectivity index (SI) and, therefore, greatly increases the likelihood of successful AVS. However, the effect of ACTH stimulation on the lateralization index (LI) is controversial, with several studies reporting a reduction in the proportion of lateralized AVS results and, therefore, of surgically treatable patients. Hitherto, most of the studies on the value of using ACTH stimulation in AVS are retrospective studies with a small sample size, or multi-center studies with ununified methods of ACTH stimulation and evaluation standards of results. Therefore, there are obvious heterogeneity in the results and the value of evidence is limited.

    In this prospective study, we analyzed the SI and LI in simultaneous bilateral AVS at baseline and after ACTH stimulation in our center, and further estimated the prognosis of patients underwent adrenalectomy with different cut-off points of LI after ACTH stimulation. Present study will provide novel evidence for the value of ACTH stimulation in AVS and improve AVS procedure.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    59 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Cross-sectional Study and Longitudinal Study of the the Value of Adrenocorticotrophic Hormonestimulation in Adrenal Vein Sampling
    Actual Study Start Date :
    Sep 1, 2021
    Anticipated Primary Completion Date :
    Oct 1, 2023
    Anticipated Study Completion Date :
    Sep 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    operative group

    Procedure/Surgery:Adrenal Vein Sampling;Adrenalectomy

    Outcome Measures

    Primary Outcome Measures

    1. Participants' personal information [1 day]

      Self-reported information (the cause of discovering adrenal adenoma)

    2. Physical assessments [1 day]

      BMI(body mess index) in kg/m^2

    3. Screening test of primary aldosteronism(Supine standing test) [1 day]

      plasma aldosterone concentration in the supine position and standing position

    4. Screening test of primary aldosteronism(Supine standing test) [1 day]

      plasma renin concentration in the supine position and standing position

    5. Confirmatory test of primary aldosteronism(Captopril test) [1 day]

      plasma aldosterone concentration at 8:00 am and 10:00 am

    6. Confirmatory test of primary aldosteronism(Captopril test) [1 day]

      plasma renin concentration at 8:00 am and 10:00 am

    7. circadian cortisol rhythm [1 day]

      adrenocorticotropic hormone at 8:00am、16:00pm and 0:00am

    8. circadian cortisol rhythm [1 day]

      Plasma cortisol concentration at 8:00am、16:00pm and 0:00am

    9. Cortisol metabolism [1 day]

      24-hours urine free cortisol

    10. 1 mg (overnight) dexamethasone suppression test [1 day]

      Plasma cortisol concentration at 8:00am

    11. Other indicators of adrenal function [1 day]

      24h urinary,plasma catecholamines and their metabolites

    12. 24-hour urine electrolytes [1 day]

      24-hour urine potassium

    13. Imaging of adrenal adenoma [1 day]

      unenhanced and contrast-enhanced CT of adrenal

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Diagnosed as primary aldosteronism.

    2. AVS was performed and conservative treatment or adrenalectomy was performed according to the results.

    3. Regular follow-up was performed.

    Exclusion Criteria:
    1. Adrenal function evaluation suggests that it is complicated with hypercortisolism, subclinical hypercortisolism and pheochromocytoma.

    2. Familial aldosteronism.

    3. .Adrenal mass is considered to be malignant, or pathology suggests adrenocortical carcinoma.

    4. .Complicated with severe infection, respiratory and circulatory failure, advanced tumor, severe. hepatic and renal insufficiency, neurological, psychiatric and immune deficiency diseases.

    5. .Drugs: discontinuation of β-receptor inhibitors, angiotensin converting enzyme inhibitors, angiotensin Ⅱ receptor blockers, thiazide diuretics < 2 weeks, aldosterone receptor antagonists < 4 weeks.

    6. .Pregnant and lactating women.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School Nanjing Jiangsu China 210008

    Sponsors and Collaborators

    • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
    ClinicalTrials.gov Identifier:
    NCT05826080
    Other Study ID Numbers:
    • lp2023
    First Posted:
    Apr 24, 2023
    Last Update Posted:
    Apr 24, 2023
    Last Verified:
    Oct 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 24, 2023